Details of the Drug
General Information of Drug (ID: DM7GW4P)
Drug Name |
4-oxo-4H-chromene-3-carboxylic acid
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Chromone-3-carboxylic acid; 39079-62-4; 4-oxo-4H-chromene-3-carboxylic acid; 4-Oxo-4H-1-benzopyran-3-carboxylic acid; 4-oxochromene-3-carboxylic acid; CHEMBL315361; PCIITXGDSHXTSN-UHFFFAOYSA-N; MFCD00017338; Maybridge1_005842; 3-carboxychromone; ACMC-1AD65; SCHEMBL1253672; AC1L49D2; CTK1C4919; ZINC57725; HMS558B12; DTXSID90192327; MolPort-000-145-536; 4-oxo-chromene-3-carboxylic acid; Chromone-3-carboxylic acid, 97%; CC-721; BDBM50131081; 4H-Chromen-4-one-3-carboxylic acid; SBB017525; AKOS001044083; CS-W015906; VZ31583
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 190.15 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 1.8 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||